Patient-Doc Task Force Building Legal Case Against Alternative Funding Programs

 
• By Sarah Karlin-Smith

From illegal importation under FDCA to possible ERISA, HIPAA and ACA violations – a task force led by CancerCare is pushing regulatory agencies with levers to go after employer plans use of alternative funding programs for specialty drugs, which they say violate multiple federal laws. 

person in business suit building a wooden block tower
Task force is building a multi-layered case against alternative funding programs that alter specialty drug coverage • Source: Shutterstock

More from Market Access

More from Pink Sheet